Faculty Directory

Daniela Drago

Daniela Drago

Associate Professor of Clinical Research and Leadership

Office Phone: 202-994-9893
Email: Email
Department: Clinical Research and Leadership

Education

  • MSc, Universita' Degli Studi Di Messina, Italy, 1997
  • PhD, Swiss Federal Institute of Technology (ETHZ), Zurich, 2001

Biography

Dr. Daniela Drago is an internationally recognized global regulatory affairs expert. Prior to joining academia, she worked in the pharmaceutical and medical device industry. She has held senior positions in global regulatory and medical affairs at F. Hoffman-La Roche, Vifor Pharma, Reckitt Benckiser and Bausch & Lomb.

Dr. Drago has substantial know-how on regulatory strategic and operational activities for a wide range of product categories, ranging from prescription-only to over the counter (OTC) drugs, medical devices, cosmetics, and other regulated fast moving consumer goods.

She is a frequent lecturer at international courses and workshops, has published numerous articles and serves on the board of directors of the Association of Graduate Regulatory Educators. Dr. Drago received her Ph.D. in Chemistry from the Swiss Federal Institute of Technology (ETH Zurich).

Bibliography

  • Drago D., Yap M., Ekmekci O.," Increasing the Odds of Effective Drug Development: Elevating Regulatory Affairs Professionals to Strategic Partners,” Clinical Research and Regulatory Affairs, in press.
  • Drago D., Shire S., Ekmekci O.,"Improving Regulatory Education: Can We Reconcile Employers’ Expectations With Academic Offerings?,” Therapeutic Innovation & Regulatory Science, first published on December 31, 2015 as doi:10.1177/2168479015620440.
  • Shire S., Swanson C., Drago D., Feagin J. “Core Competencies Provide a Roadmap for Strengthening Regulatory Education”, Regulatory Focus, September 2014.
  • Singer N., Drago D. Getting Cooperation for Regulatory Compliance, June 2014.
  • Drago D., Shire S., Swanson C., Feagin J. “Answering the Call for Excellence in Regulatory Education”, Regulatory Focus, May 2014.
  • Drago D., “Should I consider a career in Regulatory Affairs?” Medical Device and Diagnostic Industry (MD+DI), August 2013.
  • Drago, D.Pregosin, P.S.; Pfaltz, A.Chem Comm 2002, 3, 286. “Selective anion effects in chiral complexes of iridium via diffusion and HOESY data: relevance to catalysis”.
  • Drago, D.; Pregosin, P.S. Organometallics 2002, 21, 1208“Palladium-Duphos structural and enantioselective hydroarylation chemistry”.
  • Geldbach, T.J., Drago, D.Pregosin,P.S. J. Organomet. Chem2002643, 214.” A weak η1 π-bonding mode for Ru-arene complexes. Nitrile, isonitrile and phosphine derivatives of Ru-phosphino-arene chelating complexes”.
  • denReijer, C.J.; Drago, D.; Pregosin, P.S. Organometallics 2001, 20, 2982. “Ruthenium (II)-MeO-Biphep-Arene Dications: Acetylene Reactions and Unexpected Cyclometalation”.
  • Drago, D., Pregosin, P.S. J Chem Soc Dalton 2000, 18, 3191.”Allyl, olefin, aryl and alkyl organometallic palladium complexes of 1, 2-bis [(2R, 5R)-2, 5-dimethylphospholanyl] benzene”.
  • Geldbach, T.J., Drago, D., Pregosin,P.S. Chem Comm 2000, 17, 1629.” Alcohol induced stereospecific P–C bond cleavage to afford Ru–phenyl derivatives containing three different types of stereogenicity: novel and unprecedented complexes of P(OH)(OR)Ph”.
  • Drago, D., Pregosin, P.S., Razavi, A. Organometallics 2000, 9, 1802. “13C NMR Studies on Zr (ansa-Fluorenyl) Complexes. Molecules with Flexible Bonding Modes”.
  • Drago, D., Pregosin, P.S., Tschoerner, M.,Albinati, A. J Chem SocDalton 1999, 14, 2279.” Structural distortions in Pd–MeO-Biphep and Pd–Binap aryl complexes. Anomalies induced via electronic effects”.
  • Arena, C.G., Drago, D., Panzalorto, M., Bruno, G., Faraone, F. Inorg ChimActa 1999, 292, 84. “Diphosphinito-bridged ruthenium(II) and rhodium(III) complexes with stereogenic metal centers”.
  • Arena, C.G., Drago, D., Faraone, F. J MolCatal, 1999, 144, 379.” Hydroformylation of styrene and 1-octene catalyzed by binuclear and oligomer rhodium(I) complexes containing the bis-p-phosphinito ligands [(p-Ph2POC6H4)2X] (X=O, CMe2, S)”.

Teaching

Dr. Drago teaches in the School of Medicine and Health Sciences.

Programs

  • Clinical and Translational Research
  • Clinical Management and Leadership
  • Clinical Research Administration
  • Core Curriculum in Health Sciences
  • Regulatory Affairs
  • Translational Health Sciences

Publications

View publications by this faculty member from January 1, 2013 - present

Additional publications published before January 1, 2013 may be available within Himmelfarb Library's database.

Industry Relationships and Collaborations

This faculty member (or a member of their immediate family) has reported a financial interest with the health care related companies listed below. These relations have been reported to the University and, when appropriate, management plans are in place to address potential conflicts.

  • None